<DOC>
	<DOCNO>NCT01203982</DOCNO>
	<brief_summary>The aim study measure effect moderate intensive lipid-lowering treatment rosuvastatin carotid intima-media thickness ( CIMT ) surrogate marker cardiovascular risk .</brief_summary>
	<brief_title>Effect Intensive Lipid Lowering Treatment Compared Moderate Lipid Lowering Treatment Carotid Intima-media Thickness ( CIMT )</brief_title>
	<detailed_description>The aim study measure effect moderate ( 5mg ) intensive ( 40mg ) lipid-lowering treatment rosuvastatin carotid intima-media thickness surrogate marker cardiovascular risk obtain whether CIMT correlate plaque component coronary artery evaluate Intravascular Ultrasound Virtual Histology ( IVUS-VH ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . STEMI , 2. prior treatment statins 3. non significant lesion one two nonculprit coronary artery . 1. age 18 81 year , 2. unconscious patient , 3. serum creatinine &gt; 176Î¼mol/L , 4. totalcholesterol &gt; 7.0 mmol/l , 5. hypothyroidism ( ( TSH &gt; 1.5 x ULN ( upper limit normal ) ) , 6. current liver disease ( ALAT &gt; 2 x ULN ) , 7. unexplained creatine kinase &gt; 3 x ULN , 8. alcohol drug abuse within last five year , 9. prior myopathy serious hypersensitivity reaction cause statin , 10. woman childbearing potential use chemical mechanical contraception , 11. pregnant breastfeed woman , 12. history malignancy unless diseasefree period five year present , 13. patient abnormal lung function test ( LFT ) , 14. participation another investigational drug study less four week enrolment present study , 15. treatment cyclosporine fibrates .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>CIMT</keyword>
	<keyword>IVUS-VH</keyword>
	<keyword>Coronary artery disease</keyword>
</DOC>